IDXX IDEXX Laboratories, Inc.
Healthcare$559.37+1.14%ClosedMarket Cap: $44.12B
As of 2026-05-25
Analyst Consensus
Consensus
Hold
Target (Consensus)
$747.50
Target (Median)
$775.00
Target Range
$640.00 - $800.00
Upside from current price: 33.6%
Rating Distribution
4 Strong Buy5 Buy5 Hold0 Sell1 Strong Sell
Recent Analyst Ratings
| Date | Firm | Action | Rating | Previous |
|---|---|---|---|---|
| 2026-04-28 | UBS | maintain | Neutral | Neutral |
| 2026-03-31 | Stifel | maintain | Buy | Buy |
| 2026-02-09 | Piper Sandler | maintain | Neutral | Neutral |
| 2026-02-05 | Barclays | maintain | Overweight | Overweight |
| 2026-02-03 | UBS | maintain | Neutral | Neutral |
| 2026-02-03 | BTIG | maintain | Buy | Buy |
| 2025-11-04 | Morgan Stanley | maintain | Overweight | Overweight |
| 2025-11-04 | JP Morgan | maintain | Overweight | Overweight |
| 2025-11-04 | UBS | maintain | Neutral | Neutral |
| 2025-11-04 | BTIG | maintain | Buy | Buy |
Forward Estimates
| Period | EPS Est. | Revenue Est. | # Analysts |
|---|---|---|---|
| Fri Dec 31 | $16.57 | $5.12B | 11 |
| Sun Dec 31 | $18.76 | $5.59B | 8 |
| Mon Dec 31 | $21.55 | $6.14B | 6 |
| Tue Dec 31 | $26.10 | $6.98B | 6 |